Administrative data from a Canadian province were accessed to assess the association of psychotic disorders with multiple sclerosis (MS). Physician-assigned ICD-9-CM codes were used to classify MS and psychotic disorder status. A significant association was observed. Additional research is needed to determine the clinical importance and treatment needs of this population.
There are case reports and clinical studies describing the occurrence of psychotic syndromes in multiple sclerosis (MS). These reports have variably described syndromes resembling schizophrenia, 1 delusional disorders, 2 affective psychoses, 1, 3 or delirium. 4, 5 One study reported more lesions in periventricular white matter surrounding the temporal horns of the lateral ventricles in MS patients with psychotic syndromes. 1 Recent reviews have concluded that the occurrence of psychotic disorders in MS is uncommon, perhaps not exceeding chance expectation. 6 However, it has not thus far been possible to base such assertions on epidemiologic evidence. The lack of population-based studies probably relates to prohibitive sample size requirements. 6 In the Canadian province of Alberta, two circumstances combine to make an epidemiologic investigation possible. First, the province has a high prevalence of MS. Second, a universal health care system leads to data availability for the entire population of the province.
Methods. Data for this study derive from a universal public health care insurance system in the Canadian province of Alberta: the Alberta Health Care Insurance Plan (AHCIP). In Alberta, to be paid for services, physicians must submit a "fee for service" billing to the AHCIP. These billing submissions include a diagnosis, using the International Classification of Disease, ninth edition, Clinical Modification (ICD-9-CM; for information on this coding system, see http://www.cdc.gov/nchs/products/elec_prods/ subject/icd96ed.htm). AHCIP data can be used for surveillance and epidemiologic research and are particularly useful for rare diseases that would otherwise be difficult to study.
The current analysis included all residents of Alberta who were aged 15 years or older in 2002 (n ϭ 2.45 million). For MS case identification, a longitudinal record maintained by the provincial government's Health Surveillance Branch was used. This record covers the period 1985 to 2003. Cases of MS are defined as those with two or more physician services for MS (ICD-9-CM 340) during this period.
A similar procedure was used to identify subjects with psychotic disorders. Two relevant ICD-9-CM diagnostic code submissions assigned between 1994 and 2003 were used to identify subjects with psychotic disorders. The shorter time interval was selected so that subjects with a distant history of psychosis would not be included. Codes categorized by ICD-9-CM as "non-organic" and "non-affective" psychotic disorders-295 (schizophreniaspectrum disorders), 297 (delusional disorders), and 298 (other non-organic psychoses)-were used to define the psychotic disorders category. An organic psychotic disorders category was further defined using broad ICD-9-CM categories that include organic psychotic disorders-292 (drug-induced psychotic disorders), 293 (other transient organic psychotic disorders), and 294 (other organic psychotic disorders). Dementia and alcohol-related psychoses were excluded from this definition.
Logistic regression was used to evaluate the association between psychotic disorders and MS. Initially, all three-way (age group by sex by MS) and two-way (age group by sex, age group by MS, sex by MS) interaction terms were included in the models. The Wald test, in SAS, 7 was used to identify variables that could be removed from the model, based on p Ͼ 0.05.
Results.
The study sample (n ϭ 2.45 million) consisted of 1.22 million men (49.6%) and 1.23 million women (50.4%) ranging in age from 15 to 107 years (mean age 42.4 years). There were 10,367 people with MS. The total population of the province in 2002 was 3.13 million, leading to an estimated MS prevalence of 330 per 100,000. MS was more common in women (odds ratio [OR] 2.6; 95% CI 2.4 to 2.7). The prevalence of psychotic disorders was 1.3%, and that of organic psychotic disorders was 0.5%.
The prevalence of psychotic disorders increased with age in subjects without MS. In those with MS, the prevalence was highest in the 15-to 24-year age group ( figure 1) . The difference between the two groups diminished with age. The prevalence of organic psychotic disorders also increased with age, but people with MS consistently had a higher prevalence (figure 2).
Separate logistic regression models were fit for psychotic disorders and organic psychotic disorders. In the model for psychotic disorders, there was no evidence of three-way interactions (Wald 2 values: 0.07, 2.56, 0.22; p ϭ 0.78, 0.11, 0.63) or of MS by sex interaction (Wald 2 1.99; p ϭ 0.16). However, all three MS by age group interaction terms were significant, as were all three of the age group by sex interactions. The model predicted four different effects of MS, with the associated ORs being 6.6 in the 15-to 24-year age group, 2.2 in the 25-to 44-year age group, 1.9 in the 45-to 64-year age group, and 1.1 in the 65 years and older age group. A detailed summary of the model is presented in the table. The only regression term that does not achieve significance in this model is the main effect for MS. In view of the interactions, this can be inter-preted as meaning that a significant association between MS and psychotic disorders may not exist at or above age 65 years. A logistic regression model predicting organic psychotic disorders was similar, except that the main effect of MS was significant, providing evidence of an association in all age groups. In keeping with the tabular analysis, the model predicts peak prevalence in subjects aged 65 years or older, at approximately 3%. However, the strongest relative effect is found in the 15-to 24-year age group because of the very low prevalence in non-MS subjects. Here, the OR was 11.1, compared with 7.4 in the 25to 44-year age group, 5.6 in the 45-to 64-year age group, and 1.9 in the 65 years and older age group.
Discussion. This study is the first to provide epidemiologic evidence of an association between MS and psychotic disorders in the general population. Age but not sex was found to modify the observed association of psychotic disorders with MS. The main weakness of the study relates to a lack of clinical detail in the data source. This is, to some extent, inevitable when administrative data are used for research.
Because the prevalence of MS is less than one-half of 1% of the population even in a high-prevalence area such as Alberta and psychotic disorders affect only a small proportion of these individuals, the impact of this comorbidity on population health may not be great. However, among people with MS, a prevalence in the range of 2 to 3% is by no means trivial. The treatment needs of this group should now be characterized so that appropriate clinical and service delivery strategies can be developed. 
